Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Cango (灿谷好车) IPO: Moving Parts Making Valuation Tricky

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

<p>Cango, a China-based automotive transaction service platform, is planning to raise USD 300 million via its US listing. In this insight, we will have a brief look at the following subjects:</p>
<ul>
<li>The company's background, business model and reporting segments</li>
<li>Key operating metrics</li>
<li>Industry overview</li>
<li>Peer valuation</li>
</ul>
<p>We will provide our final view on the deal in our next insight. </p>

Cango, a China-based automotive transaction service platform, is planning to raise USD 300 million via its US listing. In this insight, we will have a brief look at the following subjects:

The company's background, business model and reporting segments
Key operating metrics
Industry overview
Peer valuation

We will provide our final view on the deal in our next insight. 

Cango (灿谷好车) IPO: A Leading Tech-Driven Auto Finance Player but Slow Growth Concerns Us

Cango Inc

Cango (灿谷好车) IPO: A Leading Tech-Driven Auto Finance Player but Slow Growth Concerns Us